Lonza chooses Synpromics’ novel inducible promoter platform to manufacture biopharmaceuticals
Synpromics Ltd, the leader in gene control, and Lonza Pharma & Biotech announce a partnership for the commercialisation of a number of...
Do you have news for the Scottish Life Sciences Community?
Submit Your Own News